Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Melamine In U.S. Could Pose More Risk To Food Safety Regime Than Infants

This article was originally published in The Tan Sheet

Executive Summary

FDA says trace amounts of melamine found in U.S.-manufactured infant formula poses no danger, but the discovery will likely lead to a renewed push for food safety oversight and possibly for a separate food safety agency
Advertisement

Related Content

Finished Product Manufacturers Top FDA’s GMP Inspection Targets
China Takes "Baby Steps" Toward More Open Supplement Regulation
Recall Strategy Crucial As Broader Awareness Leaves Firms Vulnerable
Formula Contamination Prompts Mandatory Recall Power In China
Mead Johnson Set Loose To Navigate Market, Shifting Economic Winds
Mead Johnson Set Loose To Navigate Market, Shifting Economic Winds 
U.S. Pharmacopeia Moves Melamine Testing Into The 21st Century
FDA Foreign Offices Are Only The Start To Improving Import Safety – Experts
FDA Maintains Miniscule Melamine Levels Pose No Risk
FDA melamine alert

Topics

Advertisement
UsernamePublicRestriction

Register

PS102358

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel